Compare $CLRB vs $INAB | Chartloom

Compare

$CLRB vs $INAB

Cellectar Biosciences Inc · IN8bio Inc

CLRB

Cellectar Biosciences Inc

INAB

IN8bio Inc

Compare $CLRB vs $INAB

Comparing Cellectar Biosciences Inc and IN8bio Inc

CLRBCellectar Biosciences Inc

INABIN8bio Inc

CLRBCellectar Biosciences Inc

Market cap

$12M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-58.2%

52W performance

-69.7%

FCF yield

-168.2%

INABIN8bio Inc

Market cap

$13M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-45.5%

52W performance

-44.4%

FCF yield

-110.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CLRB

INAB

Detailed metrics comparison

CLRB

Cellectar Biosciences Inc

INAB

IN8bio Inc

Market Cap

CLRB$12M

INAB$13M

Enterprise Value

CLRB$-22M

INAB$-5M

Price

CLRB$1.45

INAB$1.34

P/E Ratio

CLRBN/A

INABN/A

P/S Ratio

CLRB186.94x

INAB0.00x

EV/Sales

CLRB-190.77x

INAB0.00x

EV/EBITDA

CLRB0.00x

INAB0.00x

P/B Ratio

CLRB0.56x

INAB0.75x

P/FCF Ratio

CLRBN/A

INABN/A

EV/FCF

CLRB1.15x

INAB0.32x

PEG Ratio

CLRBN/A

INABN/A

Forward P/E (NTM)

CLRBN/A

INABN/A

Forward P/S (NTM)

CLRBN/A

INABN/A

Revenue (TTM)

CLRB$0

INAB$0

Revenue Growth (YoY)

CLRBN/A

INABN/A

Forward Rev Growth

CLRB585.7%

INAB1211.4%

Gross Margin (TTM)

CLRB0.0%

INAB0.0%

Operating Margin (TTM)

CLRB0.0%

INAB0.0%

EBITDA Margin (TTM)

CLRB0.0%

INAB0.0%

Net Margin (TTM)

CLRB0.0%

INAB0.0%

FCF Margin (TTM)

CLRBN/A

INABN/A

Net Income (TTM)

CLRB$-22M

INAB$-19M

FCF (TTM)

CLRB$-19M

INAB$-15M

EPS (TTM)

CLRB-$1.83

INAB-$0.96

ROE (TTM)

CLRB-16571.0%

INAB-9118.0%

ROA (TTM)

CLRB-11542.0%

INAB-7693.0%

ROIC (TTM)

CLRB-16571.0%

INAB-9006.0%

Cash

CLRB$34M

INAB$18M

Debt

CLRB$0

INAB$126K

Net Cash/Debt

CLRB$34M

INAB$18M

Current Ratio (TTM)

CLRB6.66x

INAB8.21x

Quick Ratio (TTM)

CLRB6.49x

INAB8.13x

Debt/Equity (TTM)

CLRB0.00x

INAB0.01x

Debt/Assets (TTM)

CLRB0.0%

INAB0.0%

Interest Coverage (TTM)

CLRBN/A

INABN/A

Net Debt/EBITDA (TTM)

CLRB0.00x

INAB0.00x

Beta

CLRB0.58

INAB0.24

52W Performance

CLRB-69.7%

INAB-44.4%

YTD Performance

CLRB-58.2%

INAB-45.5%

% from 52W High

CLRB-71.4%

INAB-50.9%

% from 52W Low

CLRB8.2%

INAB52.3%

Asset Turnover (TTM)

CLRB0.01x

INAB0.00x

FCF Yield (TTM)

CLRB-168.2%

INAB-110.6%

Earnings Yield (TTM)

CLRB-192.7%

INAB-141.4%

Dividend Yield (TTM)

CLRBN/A

INABN/A

Rule of 40

CLRB0.0

INAB0.0

EV/GP/RG

CLRBN/A

INABN/A

Ticker research

View CLRB research View INAB research

Metric	CLRB Cellectar Biosciences Inc	INAB IN8bio Inc
Market & Valuation
Market Cap	$12M	$13M
Enterprise Value	$-22M	$-5M
Price	$1.45	$1.34
P/E Ratio	N/A	N/A
P/S Ratio	186.94x	0.00x
EV/Sales	-190.77x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.56x	0.75x
P/FCF Ratio	N/A	N/A
EV/FCF	1.15x	0.32x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	585.7%	1211.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-22M	$-19M
FCF (TTM)	$-19M	$-15M
EPS (TTM)	-$1.83	-$0.96
ROE (TTM)	-16571.0%	-9118.0%
ROA (TTM)	-11542.0%	-7693.0%
ROIC (TTM)	-16571.0%	-9006.0%
Financial Health
Cash	$34M	$18M
Debt	$0	$126K
Net Cash/Debt	$34M	$18M
Current Ratio (TTM)	6.66x	8.21x
Quick Ratio (TTM)	6.49x	8.13x
Debt/Equity (TTM)	0.00x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.58	0.24
52W Performance	-69.7%	-44.4%
YTD Performance	-58.2%	-45.5%
% from 52W High	-71.4%	-50.9%
% from 52W Low	8.2%	52.3%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-168.2%	-110.6%
Earnings Yield (TTM)	-192.7%	-141.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CLRB research	View INAB research

Valuation

P/S Ratio

INAB

0.00x

CLRB

186.94x

EV/FCF

INAB

0.32x

CLRB

1.15x

Growth & revenue

Forward Revenue Growth

INAB

1211.4%

CLRB

585.7%

Profitability & performance

Gross Margin

CLRB

0.0%

INAB

0.0%

ROE

INAB

-9118.0%

CLRB

-16571.0%

FCF Yield %

INAB

-110.6%

CLRB

-168.2%

52-Week Performance

INAB

-44.4%

CLRB

-69.7%

Detailed metrics comparison

CLRB

Cellectar Biosciences Inc

INAB

IN8bio Inc

Market Cap

CLRB$12M

INAB$13M

Enterprise Value

CLRB$-22M

INAB$-5M

Price

CLRB$1.45

INAB$1.34

P/E Ratio

CLRBN/A

INABN/A

P/S Ratio

CLRB186.94x

INAB0.00x

EV/Sales

CLRB-190.77x

INAB0.00x

EV/EBITDA

CLRB0.00x

INAB0.00x

P/B Ratio

CLRB0.56x

INAB0.75x

P/FCF Ratio

CLRBN/A

INABN/A

EV/FCF

CLRB1.15x

INAB0.32x

PEG Ratio

CLRBN/A

INABN/A

Forward P/E (NTM)

CLRBN/A

INABN/A

Forward P/S (NTM)

CLRBN/A

INABN/A

Revenue (TTM)

CLRB$0

INAB$0

Revenue Growth (YoY)

CLRBN/A

INABN/A

Forward Rev Growth

CLRB585.7%

INAB1211.4%

Gross Margin (TTM)

CLRB0.0%

INAB0.0%

Operating Margin (TTM)

CLRB0.0%

INAB0.0%

EBITDA Margin (TTM)

CLRB0.0%

INAB0.0%

Net Margin (TTM)

CLRB0.0%

INAB0.0%

FCF Margin (TTM)

CLRBN/A

INABN/A

Net Income (TTM)

CLRB$-22M

INAB$-19M

FCF (TTM)

CLRB$-19M

INAB$-15M

EPS (TTM)

CLRB-$1.83

INAB-$0.96

ROE (TTM)

CLRB-16571.0%

INAB-9118.0%

ROA (TTM)

CLRB-11542.0%

INAB-7693.0%

ROIC (TTM)

CLRB-16571.0%

INAB-9006.0%

Cash

CLRB$34M

INAB$18M

Debt

CLRB$0

INAB$126K

Net Cash/Debt

CLRB$34M

INAB$18M

Current Ratio (TTM)

CLRB6.66x

INAB8.21x

Quick Ratio (TTM)

CLRB6.49x

INAB8.13x

Debt/Equity (TTM)

CLRB0.00x

INAB0.01x

Debt/Assets (TTM)

CLRB0.0%

INAB0.0%

Interest Coverage (TTM)

CLRBN/A

INABN/A

Net Debt/EBITDA (TTM)

CLRB0.00x

INAB0.00x

Beta

CLRB0.58

INAB0.24

52W Performance

CLRB-69.7%

INAB-44.4%

YTD Performance

CLRB-58.2%

INAB-45.5%

% from 52W High

CLRB-71.4%

INAB-50.9%

% from 52W Low

CLRB8.2%

INAB52.3%

Asset Turnover (TTM)

CLRB0.01x

INAB0.00x

FCF Yield (TTM)

CLRB-168.2%

INAB-110.6%

Earnings Yield (TTM)

CLRB-192.7%

INAB-141.4%

Dividend Yield (TTM)

CLRBN/A

INABN/A

Rule of 40

CLRB0.0

INAB0.0

EV/GP/RG

CLRBN/A

INABN/A

Ticker research

View CLRB research View INAB research

Metric	CLRB Cellectar Biosciences Inc	INAB IN8bio Inc
Market & Valuation
Market Cap	$12M	$13M
Enterprise Value	$-22M	$-5M
Price	$1.45	$1.34
P/E Ratio	N/A	N/A
P/S Ratio	186.94x	0.00x
EV/Sales	-190.77x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.56x	0.75x
P/FCF Ratio	N/A	N/A
EV/FCF	1.15x	0.32x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	585.7%	1211.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-22M	$-19M
FCF (TTM)	$-19M	$-15M
EPS (TTM)	-$1.83	-$0.96
ROE (TTM)	-16571.0%	-9118.0%
ROA (TTM)	-11542.0%	-7693.0%
ROIC (TTM)	-16571.0%	-9006.0%
Financial Health
Cash	$34M	$18M
Debt	$0	$126K
Net Cash/Debt	$34M	$18M
Current Ratio (TTM)	6.66x	8.21x
Quick Ratio (TTM)	6.49x	8.13x
Debt/Equity (TTM)	0.00x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.58	0.24
52W Performance	-69.7%	-44.4%
YTD Performance	-58.2%	-45.5%
% from 52W High	-71.4%	-50.9%
% from 52W Low	8.2%	52.3%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-168.2%	-110.6%
Earnings Yield (TTM)	-192.7%	-141.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CLRB research	View INAB research